Literature DB >> 12782171

Choroiditis in systemic lupus erythematosus: systemic steroid therapy and focal laser treatment.

Masahiko Shimura1, Yuko Tatehana, Kanako Yasuda, Shin ichiro Saito, Takeshi Sasaki, Makoto Tamai.   

Abstract

PURPOSE: To report a rare case of choroiditis in association with systemic lupus erythematosus (SLE). CASE: A 49-year-old woman with a 17-year history of SLE experienced acute vision impairment of her left eye during the remission stage of systemic SLE. Fundus examination revealed a gray-white subretinal exudate with serous retinal detachment. Angiographic examination disclosed choroidal inflammation at the macula and a breakdown of the blood retinal barrier. Retinal burns were applied to the subretinal exudate with an argon laser as in the treatment of central serous retinopathy. Afterward, her visual acuity showed prompt recovery due to the regression of the serous retinal detachment. However, the choroidal inflammation remained until the systemic condition was controlled with steroid therapy.
RESULTS: Laser treatment of a subretinal exudate was helpful for the resolution of serous detachment and the prompt improvement of visual acuity, whereas systemic steroid therapy was effective for choroidal inflammation.
CONCLUSIONS: Systemic steroid therapy is thought to be effective for SLE choroiditis; however, this therapy is also known to cause serous retinal detachment. Thus, in SLE choroiditis, laser photocoagulation at a leakage point, in addition to systemic steroid therapy, may be helpful for the prompt restoration of vision in patients with serous retinal detachment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782171     DOI: 10.1016/s0021-5155(03)00012-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  Secondary angle closure glaucoma by lupus choroidopathy as an initial presentation of systemic lupus erythematosus: a case report.

Authors:  Young Soo Han; Chan min Yang; Sang-Hoon Lee; Jae Ho Shin; Sang Woong Moon; Ja Heon Kang
Journal:  BMC Ophthalmol       Date:  2015-10-29       Impact factor: 2.209

2.  Systemic complement activation in central serous chorioretinopathy.

Authors:  Elon H C van Dijk; Roula Tsonaka; Ngaisah Klar-Mohamad; Diana Wouters; Aiko P J de Vries; Eiko K de Jong; Cees van Kooten; Camiel J F Boon
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.